• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Influenza Vaccines R&D Roadmap - Open for Comment

Shiloh

Editor, Senior Moderator
Source: https://www.cidrap.umn.edu/IVR-info

Influenza Vaccines R&D Roadmap

The Influenza Vaccines Research and Development (R&D) Roadmap (IVR) is a globally oriented R&D roadmap for improving seasonal influenza vaccines and developing broadly protective or universal influenza vaccines. By highlighting key challenges and identifying realistic goals with aligned milestones, the roadmap will serve as a strategic planning tool to enhance coordination and advance the complex field of influenza vaccine research. The current draft roadmap has been developed with input from a broad coalition of influenza experts including the steering group and taskforce. Primary audiences for the roadmap include researchers, funders, policymakers, industry leaders, regulators, and communications/advocacy specialists.

PUBLIC COMMENT PERIOD

We are soliciting public comments on the draft roadmap, enhance awareness and engagement in the IVR process, and capture a wide range of perspectives to incorporate into the roadmap.

Comments will be reviewed and the revised roadmap will be launched in June 2021.

Instructions...
 
Back
Top Bottom